Skip to main content

Want a detailed portfolio tracker?

Mural Oncology (MURA) P/E (2023 - 2026)

Mural Oncology (MURA) P/E from Nov 16, 2023 to Jul 21, 2026. The TTM Mural Oncology (MURA) P/E is -0.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mural Oncology (MURA)

YearP/EChange
2026-0.29N/A
2025-0.29-30.74%
2024-0.43-14.41%
2023-0.50N/A

Comparison Mural Oncology (MURA) P/E with competitors

Mural Oncology (MURA) P/E is -0.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.58%
NBYStablecoin Development Corp0.00-101.46%
ENLVEnlivex Ltd0.07-125.36%
FGENFibroGen Inc0.24-181.37%
CHRSCoherus Biosciences Inc0.85-387.65%
FBIOFortress Biotech Inc0.95-421.72%
ORMPOramed Pharmaceuticals Inc1.50-609.53%
AGENAgenus Inc3.01-1120.25%
INVAInnoviva Inc3.15-1169.20%
VXRTVaxart Inc3.55-1303.35%
CRMDCorMedix Inc3.63-1330.03%
CVACCureVac N.V.4.45-1607.07%
GLPGGalapagos NV4.86-1747.14%
SRPTSarepta Therapeutics Inc4.88-1755.01%
ABEOAbeona Therapeutics Inc5.39-1926.34%
ABUSArbutus Biopharma Corp5.60-1996.89%
ZVRAZevra Therapeutics Inc5.89-2095.75%
SPROSpero Therapeutics Inc6.23-2211.42%
CGENCompugen Ltd6.31-2240.40%
RIGLRigel Pharmaceuticals6.87-2429.60%
SLXNSilexion Therapeutics Corp7.30-2573.34%
OMEROmeros Corporation9.26-3238.68%
AUPHAurinia Pharmaceuticals Inc9.58-3349.27%
PLXProtalix BioTherapeutics Inc10.89-3792.01%
ACADAcadia Pharmaceuticals Inc11.73-4075.93%
TBPHTheravance Biopharma Inc12.26-4256.83%
ADMAAdma Biologics Inc12.42-4309.72%
HRMYHarmony Biosciences Holdings Inc13.82-4785.01%
SABSSAB Biotherapeutics Inc14.14-4892.13%
NAGENiagen Bioscience Inc14.82-5123.30%
INCYIncyte Corp15.82-5463.81%
REGNRegeneron Pharmaceuticals Inc15.86-5475.37%
PBYIPuma Biotechnology Inc17.32-5969.98%
CPRXCatalyst Pharmaceuticals Inc17.44-6011.88%
EXELExelixis Inc17.54-6045.34%
TGTXTG Therapeutics Inc18.97-6529.45%
MDXGMimedx Group Inc20.55-7067.25%
XOMAXOMA Royalty Corp22.87-7854.67%
ARGXArgen X SE24.30-8337.18%
CTMXCytomX Therapeutics Inc24.82-8514.52%
XOMAOXOMA Royalty Corp25.34-8692.05%
HALOHalozyme Therapeutics Inc25.62-8786.60%
XOMAPXOMA Royalty Corp25.67-8802.33%
VRTXVertex Pharmaceuticals Inc27.99-9590.40%
RPRXRoyalty Pharma plc - Class A28.69-9825.26%
SLNOSoleno Therapeutics Inc29.02-9936.39%
ASNDAscendis Pharma A/S30.09-10299.20%
LGNDLigand Pharmaceuticals Inc - Class B37.91-12952.42%
APLSApellis Pharmaceuticals Inc39.02-13328.45%
BMRNBiomarin Pharmaceutical Inc42.21-14410.09%
KRYSKrystal Biotech Inc45.34-15471.73%
ONCBeiGene Ltd69.54-23674.67%
PHARPharming Group N.V.75.03-25534.17%
TECHBio-Techne Corp101.96-34664.57%
VCELVericel Corp109.92-37364.07%
ALNYAlnylam Pharmaceuticals Inc117.96-40090.96%
GMABGenmab140.29-47659.51%
TLXTelix Pharmaceuticals Ltd162.15-55070.90%
CORTCorcept Therapeutics Inc212.86-72260.13%